Health care practitioners can find more information at carefusion.com/StartClean.About CareFusion Corporation CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.  2011 Bernstein Rein survey of 151 surgeons.  Johnson, A., Daley, J., Zywiel, M., Delanois, R. et al. "Preoperative chlorhexidine preparation and the incidence of surgical site infections after hip arthroplasty," September 2010, The Journal of Arthroplasty, 25(6):98–102.  Stockwell MS, et al "Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: A randomized controlled trial" JAMA 2012;307: 1702-1708. SOURCE CareFusion Corp.